FILTER
FILTERED ARTICLE RESULTS
Financing Early Stage Drug Candidates Through Their Future Royalties: A New Form of Capital
May 23, 2019
Expert Opinion Article contributed by Jim Neal, CEO of the biotech enterprise XOMA.
Serialization Regulations Put Packaging Into the Limelight
April 24, 2019
Changing serialization requirements represent an opportunity for packaging companies that are looking to add value for their clients.
Breaking Down Drug Pricing
April 01, 2019
The U.S. biopharmaceuticals industry continues to grapple with the perennial issue of drug pricing.
Standing Out in the Biotech Crowd: The VC Investment Climate
February 06, 2019
With biotechs now accounting for 70% of clinical trials in the United States, the VC private investment climate is heating up.
The Indispensable Partner: Contract Services
October 31, 2018
Large Pharma companies often turn to CMOs and CDMOs for specialized expertise, while Biotech startups rely upon their labs and hardware, resulting in a rapidly expanding and increasingly global business.
From Volume to Value: A Shift in Innovation Focus in the U.S.
August 30, 2018
Precision medicine and the understanding that every patient is different are driving drug discovery.
R&D: Is Innovation Really Happening in China?
August 09, 2018
With an ever-increasing stockpile of innovative technologies and a growing network of talented scientists intently focused on innovation, it will merely be a matter of time before China begins to produce some of the most cutting-edge drugs.
Patient Selection: The Right Drug for the Right Patient
June 06, 2018
By better defining addressable patient populations and more precisely predicting likely individual responses, companies are able to reduce a great deal of risk in their clinical trials.
Infectious Diseases: Addressing Growing Resistance
April 26, 2018
The infectious disease space is one of high unmet need. However, this particular market segment carries an additional challenge: drug resistance.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Latin America Petrochemicals and Chemicals 2024 - Digital Interactive
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
